{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:54:32Z","timestamp":1767707672382},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,2,26]],"date-time":"2007-02-26T00:00:00Z","timestamp":1172448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1471-2296-8-6","type":"journal-article","created":{"date-parts":[[2007,2,27]],"date-time":"2007-02-27T13:11:43Z","timestamp":1172581903000},"source":"Crossref","is-referenced-by-count":19,"title":["The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden"],"prefix":"10.1186","volume":"8","author":[{"given":"Ingela","family":"Bj\u00f6rholt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stina","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar H","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingvar","family":"Krakau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,2,26]]},"reference":[{"key":"212_CR1","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/eurheartj\/14.10.1427","volume":"14","author":"K Asplund","year":"1993","unstructured":"Asplund K, Beerman B, Bergfeldt L, Blomstr\u00f6m P, Blomstr\u00f6m Lundqvist C, Boman K, Britton M, Dale J, Edvardsson N, Forfang K, Godtfredsen J, Gustafsson C, Juul-M\u00f6ller S, Norrving B, Olsson B, Rehnqvist N, Ronvall J: Treatment of atrial fibrillation. Recommendations from a workshop arranged by the Medical Products Agency (Uppsala, Sweden) and the Swedish Society of Cardiology. Eur Heart J. 1993, 14: 1427-1433.","journal-title":"Eur Heart J"},{"key":"212_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/028134301750235358","volume":"19","author":"PE W\u00e4ndell","year":"2001","unstructured":"W\u00e4ndell PE: Five-year mortality in men and women with atrial fibrillation. Scand J Prim Health Care. 2001, 19: 112-116. 10.1080\/028134301300034567.","journal-title":"Scand J Prim Health Care"},{"key":"212_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6904-4-1","volume":"4","author":"G Nilsson","year":"2004","unstructured":"Nilsson G, Bj\u00f6rholt I: Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: A retrospective study on electronic patient records. BMC Clinical Pharmacology. 2004, 4: 1-10.1186\/1472-6904-4-1.","journal-title":"BMC Clinical Pharmacology"},{"key":"212_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","volume":"155","author":"WM Feinberg","year":"1995","unstructured":"Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG: Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med. 1995, 155: 469-473. 10.1001\/archinte.155.5.469.","journal-title":"Arch Intern Med"},{"key":"212_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/02813430118883","volume":"19","author":"PE W\u00e4ndell","year":"2001","unstructured":"W\u00e4ndell PE: A survey of subjects with present or previous atrial fibrillation in a Swedish community. Scand J Prim Health Care. 2001, 19: 20-24. 10.1080\/028134301300034567.","journal-title":"Scand J Prim Health Care"},{"issue":"3","key":"212_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1212\/WNL.51.3.674","volume":"51","author":"RG Hart","year":"1998","unstructured":"Hart RG, Sherman DG, Easton JD, Cairns JA: Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology. 1998, 51 (3): 674-681.","journal-title":"Neurology"},{"key":"212_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S1088-3371(97)00002-8","volume":"1","author":"JJ Caro","year":"1997","unstructured":"Caro JJ, O'Brien JA, Klittich W, Jackson JD: The economic impact of warfarin prophylaxis in nonvalvular atrial fibrillation. Disease Management and Clinical Outcome. 1997, 1: 54-60. 10.1016\/S1088-3371(97)00002-8.","journal-title":"Disease Management and Clinical Outcome"},{"key":"212_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1046\/j.1532-5415.2002.50212.x","volume":"50","author":"N Desbiens","year":"2002","unstructured":"Desbiens N: Deciding on anticoagulating the oldest old with atrial fibrillation: Insights from cost-effectiveness analysis. J Am Geriatr Soc. 2002, 50: 863-869. 10.1046\/j.1532-5415.2002.50212.x.","journal-title":"J Am Geriatr Soc"},{"key":"212_CR9","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1001\/jama.1995.03530230025025","volume":"274","author":"BF Gage","year":"1995","unstructured":"Gage BF, Cardinalli AB, Albers GW, Owens DK: Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with non-valvular atrial fibrillation. JAMA. 1995, 274: 1839-1845. 10.1001\/jama.274.23.1839.","journal-title":"JAMA"},{"key":"212_CR10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1136\/bmj.305.6867.1457","volume":"305","author":"C Gustafsson","year":"1992","unstructured":"Gustafsson C, Asplund K, Britton M, Norrving B, Olsson B, Mark\u00e9 L-\u00c5: Cost effectiveness of primary stroke prevention in atrial fibrillation: a Swedish national perspective. BMJ. 1992, 305: 1457-1460.","journal-title":"BMJ"},{"key":"212_CR11","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1161\/01.STR.29.9.1827","volume":"29","author":"S Lightowlers","year":"1998","unstructured":"Lightowlers S, McGuire A: Cost-effectiveness of anticoagulation in nonrheumatic atrial fibrillation in the primary prevention of ischemic stroke. Stroke. 1998, 29: 1827-1832.","journal-title":"Stroke"},{"key":"212_CR12","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(00)90012-6","volume":"355","author":"R Thompson","year":"2000","unstructured":"Thompson R, Parkin D, Eccles M, Sudlow M, Robinson A: Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet. 2000, 355: 956-962. 10.1016\/S0140-6736(00)90012-6.","journal-title":"Lancet"},{"issue":"6","key":"212_CR13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/fampra\/cmh606","volume":"21","author":"G Nilsson","year":"2004","unstructured":"Nilsson G, Bj\u00f6rholt I, Krakau I: Anticoagulant treatment of patients with chronic atrial fibrillation in primary health care in Sweden \u2013 a retrospective study of incidence and quality in a registered population. Fam Pract. 2004, 21 (6): 612-6. 10.1093\/fampra\/cmh606.","journal-title":"Fam Pract"},{"key":"212_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2296-4-3","volume":"4","author":"G Nilsson","year":"2003","unstructured":"Nilsson G, Bj\u00f6rholt I, Johnsson H: Anticoagulant treatment in primary health care in Sweden \u2013 prevalence, incidence and treatment diagnosis: A retrospective study on electronic patient records in a registered population. BMC Family Practice. 2003, 4: 3-10.1186\/1471-2296-4-3.","journal-title":"BMC Family Practice"},{"key":"212_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-2296-7-67","volume":"7","author":"S Andersson","year":"2006","unstructured":"Andersson S, Bj\u00f6rholt I, Nilsson GH, Krakau I: Resource consumption and management associated with monitoring of warfarin treatment in primary health care in Sweden. BMC Family Practice. 2006, 7: 67-10.1186\/1471-2296-7-67.","journal-title":"BMC Family Practice"},{"issue":"2 Pt 1","key":"212_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2165\/00019053-199712020-00003","volume":"12","author":"C Evans","year":"1997","unstructured":"Evans C: The use of consensus methods and expert panels in pharmacoeconomic studies. \u2013 practical applications and methodological shortcomings. Pharmacoeconomics. 1997, 12 (2 Pt 1): 121-129.","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"212_CR17","first-page":"29","volume":"7","author":"N Jairath","year":"1994","unstructured":"Jairath N, Weinstein J: The Delphi methodology (part one): A useful administrative approach. Can J Nurs Adm. 1994, 7 (3): 29-42.","journal-title":"Can J Nurs Adm"},{"issue":"4","key":"212_CR18","first-page":"7","volume":"7","author":"N Jairath","year":"1994","unstructured":"Jairath N, Weinstein J: The Delphi methodology (part two): A useful administrative approach. Can J Nurs Adm. 1994, 7 (4): 7-20.","journal-title":"Can J Nurs Adm"},{"key":"212_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","volume":"311","author":"J Jones","year":"1995","unstructured":"Jones J, Hunter D: Consensus methods for medical and health services research. BMJ. 1995, 311: 376-380.","journal-title":"BMJ"},{"key":"212_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2648.1994.tb01066.x","volume":"19","author":"PL Williams","year":"1994","unstructured":"Williams PL, Webb C: The Delphi technique: A methodological discussion. Journal of Advanced Nursing. 1994, 19: 180-186. 10.1111\/j.1365-2648.1994.tb01066.x.","journal-title":"Journal of Advanced Nursing"},{"key":"212_CR21","unstructured":"Vad g\u00f6r l\u00e4karna?. [\n                    http:\/\/www.ihe.se\/publiceringar\/vad_gor_lakarna.htm\n                    \n                  ]"},{"key":"212_CR22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1017\/S0266462304001217","volume":"20","author":"O Ghatnekar","year":"2004","unstructured":"Ghatnekar O, Persson U, Glader EL, Terent A: Cost of stroke in Sweden:an incidence estimate. Int J Technol Assess Health Care. 2004, 20: 375-380.","journal-title":"Int J Technol Assess Health Care"},{"key":"212_CR23","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1517\/14656566.7.15.2079","volume":"7","author":"S Elderhy","year":"2006","unstructured":"Elderhy S, Cohen A: Optimising stroke prevention in non-valvular atrial fibrillation. Expert Opin Pharmacother. 2006, 7: 2079-2094. 10.1517\/14656566.7.15.2079.","journal-title":"Expert Opin Pharmacother"}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2296-8-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-8-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-8-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-8-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T14:46:59Z","timestamp":1548254819000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/1471-2296-8-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,26]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1186\/1471-2296-8-6","relation":{},"ISSN":["1471-2296"],"issn-type":[{"value":"1471-2296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,26]]},"article-number":"6"}}